TY - JOUR
T1 - Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment
AU - Qiao, H.
AU - Noda, Y.
AU - Kamei, H.
AU - Nagai, T.
AU - Furukawa, H.
AU - Miura, H.
AU - Kayukawa, Y.
AU - Ohta, T.
AU - Nabeshima, T.
PY - 2001/1/22
Y1 - 2001/1/22
N2 - Phencyclidine (PCP) reduced social behavior (SB) in a dose- and time-dependent fashion. However, no such SB deficit was observed on repeated treatment with methamphetamine for 14 days. The SB deficit produced by treatment with PCP (10mg/kg/day) for 14 days, which persisted for 28 days after withdrawal, was attenuated by clozapine (10 mg/kg/day) given for 7 days, whereas haloperidol for 7 days had no effect. Clozapine, but not haloperidol, alone at the same treatment dose increased SB in saline-treated mice. These results suggest that the proposed PCP model in mice will provide a tool to test beneficial effects of atypical antipsychotics on social dysfunction in schizophrenia, and contribute to our understanding of the mechanisms by which clozapine improves SB deficit.
AB - Phencyclidine (PCP) reduced social behavior (SB) in a dose- and time-dependent fashion. However, no such SB deficit was observed on repeated treatment with methamphetamine for 14 days. The SB deficit produced by treatment with PCP (10mg/kg/day) for 14 days, which persisted for 28 days after withdrawal, was attenuated by clozapine (10 mg/kg/day) given for 7 days, whereas haloperidol for 7 days had no effect. Clozapine, but not haloperidol, alone at the same treatment dose increased SB in saline-treated mice. These results suggest that the proposed PCP model in mice will provide a tool to test beneficial effects of atypical antipsychotics on social dysfunction in schizophrenia, and contribute to our understanding of the mechanisms by which clozapine improves SB deficit.
UR - http://www.scopus.com/inward/record.url?scp=0035931424&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035931424&partnerID=8YFLogxK
U2 - 10.1097/00001756-200101220-00010
DO - 10.1097/00001756-200101220-00010
M3 - Article
C2 - 11201068
AN - SCOPUS:0035931424
SN - 0959-4965
VL - 12
SP - 11
EP - 15
JO - Neuroreport
JF - Neuroreport
IS - 1
ER -